D. E. Shaw & Co., Inc.

Position in ASND — Ascendis Pharma A/S

CIK 1009207 New York, NY

Back to ASND Full portfolio

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$242,911

-$26,575,856 QoQ

Shares Held

1,062

-99.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Mar 31, 2026

CallValue

$11,001,913

CallShares

48,100

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. ASND ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

All Filings in ASND

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$242,911	1,062	-97.8%	Shares	Defined	2026-05-15
2026-03-31	$11,001,913	48,100	+743.9%	Call	Defined	2026-05-15
2025-12-31	$1,215,468	5,700	-95.5%	Call	Defined	2026-02-17
2025-12-31	$26,818,767	125,768	+2415.4%	Shares	Defined	2026-02-17
2025-09-30	$994,050	5,000	+39.4%	Call	Defined	2025-11-14
2025-09-30	$712,932	3,586	-50.1%	Shares	Defined	2025-11-14
2025-06-30	$1,240,303	7,186	+43.7%	Shares	Defined	2025-08-14
2025-06-30	$863,000	5,000	0.0%	Call	Defined	2025-08-14
2025-03-31	$779,300	5,000	-75.6%	Call	Defined	2025-05-15
2025-03-31	$3,199,182	20,526	+310.5%	Shares	Defined	2025-05-15
2024-12-31	$688,350	5,000	-86.8%	Call	Defined	2025-02-14
2024-12-31	$5,228,706	37,980	-58.0%	Shares	Defined	2025-02-14
2024-09-30	$13,494,637	90,380	+1707.6%	Shares	Defined	2024-11-14
2024-09-30	$746,550	5,000	-98.2%	Call	Defined	2024-11-14
2024-06-30	$38,396,016	281,537	-17.2%	Shares	Defined	2024-08-14
2024-03-31	$51,415,638	340,118	+28.3%	Shares	Defined	2024-05-15
2023-12-31	$33,396,523	265,157	+20.2%	Shares	Defined	2024-02-14
2023-09-30	$20,652,582	220,553	+67.0%	Shares	Defined	2023-11-14
2023-06-30	$11,788,407	132,083	-5.1%	Shares	Defined	2023-08-14
2023-03-31	$14,926,739	139,216	+19.3%	Shares	Defined	2023-05-15
2022-12-31	$14,253,059	116,704	+27.1%	Shares	Defined	2023-02-14
2022-09-30	$9,480,300	91,810	-8.0%	Shares	Defined	2022-11-14
2022-06-30	$9,275,734	99,782	-34.3%	Shares	Defined	2022-08-15
2022-03-31	$17,833,907	151,959	-1.7%	Shares	Defined	2022-05-16
2021-12-31	$20,801,027	154,620	+1832.8%	Shares	Defined	2022-02-14
2021-09-30	$1,275,120	8,000	-67.8%	Put	Defined	2021-11-15
2021-09-30	$3,957,175	24,827	+210.3%	Shares	Defined	2021-11-15
2021-06-30	$1,052,400	8,000	+30.8%	Put	Defined	2021-08-16
2021-06-30	$804,691	6,117	-23.5%	Shares	Defined	2021-08-16
2021-03-31	$1,031,040	8,000	-4.4%	Put	Defined	2021-05-17
2021-03-31	$1,078,338	8,367	-63.0%	Shares	Defined	2021-05-17
2020-12-31	$3,770,561	22,608	+38.1%	Shares	Defined	2021-02-16
2020-09-30	$2,525,446	16,365	-18.8%	Shares	Defined	2020-11-16
2020-06-30	$2,979,593	20,146	+0.7%	Shares	Defined	2020-08-14
2020-03-31	$2,252,086	19,999	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.